Delivery Order SPE2DB22D1041-SPE2DB23FP6LP
Award Date 8/30/23
Potential Completion Date 8/31/23
Potential Value $3.5K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $275,860 firm fixed price delivery order to AmerisourceBergen Drug Corporation for the supply of 90 tablets of 2.5 mg Letrozole, an aromatase inhibitor used to treat breast cancer. The order was placed under an existing prime vendor contract vehicle to provide pharmaceutical products and services to DLA and the Department of Defense. Performance will take place at AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania, with delivery...
- The Defense Logistics Agency awarded a $32,400 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 90 boxes containing 2.5 mg tablets of Letrozole, an aromatase inhibitor used as a breast cancer treatment. To be performed under contract at Amerisourcebergen's facility located in Conshohocken, Pennsylvania, the order requires delivery by August 28, 2023 to support the DLA's medical supply needs. No subcontractors or set aside designations were indicated. The...
- The Defense Logistics Agency awarded a $10,258.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 90 tablets of 2.5 mg Letrozole, an aromatase inhibitor used to treat breast cancer. The contract has a period of performance from August 11 to August 14, 2023, with all products to be delivered from the contractor's facility located in Conshohocken, Pennsylvania. No subcontractors or set aside designations were identified. The Defense Logistics Agency...
- The Defense Logistics Agency awarded a delivery order valued at $420.04 to Amerisourcebergen Drug Corporation for the supply of 90 tablets of 2.5 mg Letrozole, an aromatase inhibitor used to treat breast cancer. The firm fixed price contract has a period of performance from August 2, 2023 through August 3, 2023, with all products to be delivered to the contractor's facility in Conshohocken, Pennsylvania. No major subcontractors or set aside designations were identified. The Defense Logistics...
- The Defense Logistics Agency awarded a $98,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 90 packages containing 2.5 mg tablets of Letrozole, an aromatase inhibitor used to treat breast cancer. The order was placed under an existing prime vendor contract vehicle and will be fulfilled from Amerisourcebergen's distribution center located in Conshohocken, Pennsylvania. Performance is required between August 21-22, 2023. No subcontractors or set aside...
- The Defense Logistics Agency Troop Support Medical awarded a $370.97 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for the supply of 90 tablets of 2.5 mg Letrozole, an aromatase inhibitor used to treat breast cancer. The place of performance is Conshohocken, Pennsylvania. The delivery order period of performance is from July 31, 2023 through August 1, 2023 under the DLA's Prime Vendor Program indefinite-delivery/indefinite-quantity contract vehicle....
- Defense Logistics Agency awarded an $18 delivery order to Amerisourcebergen Drug Corp for the supply of 30 tablets of 2.5 mg Letrozole per package. The order was awarded on October 13, 2023 under Amerisourcebergen's corporate office blanket purchase agreement and is to be completed by October 16, 2023. The firm fixed price order will be fulfilled from Amerisourcebergen's facility located in Conshohocken, Pennsylvania. No set aside designation was applied to this order for the pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Letrozole 2.5 mg tablets (90-count units) under a firm fixed-price contract valued at $1,552.54. The award was made on September 24, 2025, with an ultimate completion date of September 25, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania location. This non-competitive delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately one thousand fifty-eight dollars and thirty-six cents to Amerisourcebergen Drug Corporation for ninety tablets of the two and a half milligram strength of the breast cancer drug letrozole. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between September fourteenth and fifteenth of twenty twenty-three. The prime...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, valued at $1,081.68, for the supply of Letrozole 2.5 mg tablets in a quantity of 90 units. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order with an ultimate completion date of August 6, 2025. The award was issued on August 5, 2025, with performance to be executed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. Letrozole is a...
- SPE2DB22D1041Indefinite Delivery Contract
- SPE2DB22D1041-SPE2DB23FP6LPDelivery Order
The Defense Logistics Agency awarded a $3,458 delivery order to Amerisourcebergen Drug Corporation for the supply of 90 tablets of 2.5 mg Letrozole, an aromatase inhibitor used to treat breast cancer. The firm fixed price order is being fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania for delivery between August 30 and August 31, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and supply chain to support the military services and combatant commands. This delivery order was awarded under an existing indefinite-delivery/indefinite-quantity contract vehicle to fulfill critical pharmaceutical needs for DOD medical treatment programs on an as-needed basis.
Generated 12/14/23, 8:52 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 8/30/23 |